KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,428 | +170.4% | 44,928 | +265.9% | 0.00% | – |
| Q2 2023 | $22,348 | -52.3% | 12,279 | 0.0% | 0.00% | – |
| Q1 2023 | $46,844 | -68.6% | 12,279 | -13.8% | 0.00% | – |
| Q1 2021 | $149,000 | -54.8% | 14,239 | -33.8% | 0.00% | – |
| Q4 2020 | $330,000 | +16.6% | 21,525 | +12.1% | 0.00% | – |
| Q3 2020 | $283,000 | -20.1% | 19,198 | +2.7% | 0.00% | -100.0% |
| Q2 2020 | $354,000 | +40.5% | 18,688 | +39.5% | 0.00% | 0.0% |
| Q1 2020 | $252,000 | – | 13,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |